ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.
ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.
A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)
Inclusion Criteria
Exclusion Criteria
Clinical.Trials@bms.com855-907-3286
Daphne, Alabama 36526, United States
111-111-1111
Marietta, Georgia 30060, United States
Buenas Aires, Buenos Aires C1049AAG, Argentina
(+54911)4162-5353
SĆ£o JosĆ© do Rio Preto, SĆ£o Paulo 15090-000, Brazil
Las Condes, Arica y Parinacota Region 7560908, Chile
Hangzhou, Zhejiang 310000, China
Shanghai Shi, 200030, China
Bordeaux, Aquitaine 33076, France
Lyon Cedex08, Auvergne-RhƓne-Alpes 69373, France
33426556761
Saint-Herblain, Loire-Atlantique 44800, France
Ludwigshafen am Rhein, Rhineland-Palatinate 67063, Germany
Haile, 06120, Germany
00493455591440
Hksar, 999077, Hong Kong
+85239103299
New Delhi, National Capital Territory of Delhi 110085, India
Bunkyo Ku, Tokyo 113-8677, Japan
81-3-3823-2101
Hirakata-shi, 573-1191, Japan
Opole, Opole Voivodeship 45-061, Poland
PrzemyÅl, Podkarpackie Voivodeship 37-700, Poland
FloreČti, Cluj 407280, Romania
40742206212
Timisoara, Timis, 300239, Romania
40744571617
Cheongju-si, Chungcheongbuk-do [Chungbuk] 28644, South Korea
Seoul, Seoul-teukbyeolsi [Seoul] 03722, South Korea
L'Hospitalet Del Llobregat, Barcelona [Barcelona] 08908, Spain
303-403-7333
302-366-1200
770-281-5124
309-243-3000
260-436-0800
859-218-6704
914-242-2991
541-683-5001
503-885-5411
615-329-7274
615-322-4967
000-000-0000
512-427-9400
214-370-1000
817-759-7000
713-792-6363
210-656-7177
903-579-9800
540-381-5291
543514862400
5493416955611
+541132218900
5491132682903
11-49590200ext8159
549351368119
+61243209890
(02) 4734 1751
0288905200
08 7117 7265
61(03)53208500
+61 8 9400 9897
4351250483584
+3289808260
32933229500
3237602327
003216340961
+3234368061
5586999007799
558440095595
555133598619
17996782301
551732015054
+359889214157
0887098616
+359887623916
+359 893582321
613737770070175
514-345-3511-3793
418-656-8711
13883465672
8613696834132
13612388011
13823394075
8618163137331
13771975906
8613767120022
18560081329
86-15553181309
8613015301402
8618227667667
13958194313
13867622009
13600470913
33556333229
+33676133810
33567771837
33320444998
33555056892
33491324400
33158413091
+498214003716
+49 261 496-3510
4936419396622
004989857914001
041026012101
4956735011573
0049-(0)941-944-1728
+302107700220
306936490499
302313323959
6979490052
302413502124
+306983519989
+353 1 410 3000
+353 1 809 3000
390817770291
390434659294
390119026322
0039 3470112401
390223903829
00390257489482
+81783825660
81798456111
+81-80-5057-3533
81455202222
81227288000
81723681184
819014217189
81534352356
81925413231
81862357534
(3150)361-3532
48502313767
661957237
0040744432443
0040721245891
40745646368
40727774974
40746110096
40744692062
82432696015
+82-31-787-7041
82222284190
82230103214
821099333453
01097705707
34935565651
0034913908922
34961973500x436633
+34946006333
+34932483137
34951308130
34955008932
+0034677872686
+46 26 18 00 00
+46 8 123 700 00
+46 18 611 00 00
41(0)918119631
+41581447850
41714941111
886223368239
886289667000ext.1815
8864235925253218
88622312345662905
+44(0)161 446 3000
+44(0)1223 805000
+44 29 2061 5888
+44 1483 571122
+44 151 556 5000
+44 20 3456 7890
+44 20 7352 8171
+44 1923 826111
+44(0)20 8642 6011